Ethical Implications of Continuing Oral Immunotherapy After the Development of Eosinophilic Esophagitis.
Ethical Implications of Continuing Oral Immunotherapy After the Development of Eosinophilic Esophagitis.
复制标题
嗜酸性粒细胞性食管炎发生后继续口服免疫治疗的伦理意义。
DOI:
10.1016/j.jaip.2023.08.012
复制
发表时间:
2023
期刊:
影响因子:
--
通讯作者:
Wright,BenjaminL
中科院分区:
文献类型:
--
作者:
Wilson,BridgetE;Meltzer,EllenC;Wright,BenjaminL
Eosinophilic esophagitis (EoE) is a chronic allergic inflammatory disease requiring maintenance therapy. Traditionally, EoE has been a contraindication to oral immunotherapy (OIT) and a rationale for discontinuing treatment because OIT may induce EoE. Most, but not all patients with OIT-induced EoE experience symptom resolution and histologic remission after discontinuing OIT. Recent studies report OIT continuation even after EoE onset, despite the previously accepted standard of care. This creates clinical as well as ethical challenges for allergists treating these patients. Considering the published literature on EoE and OIT and the primary medical ethics principles of beneficence, nonmaleficence, autonomy, and justice, we discuss the ethical implications of pursuing desensitization despite the potential complications associated with EoE. When ethical principles are in opposition, shared decision-making should be employed to determine whether OIT should be continued after an EoE diagnosis. This article highlights the ethical dilemmas allergists face when determining whether patients with a diagnosis of EoE should continue OIT.